Literature DB >> 21329970

Cell-culture-derived influenza vaccine production.

W Paul Glezen1.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21329970     DOI： 10.1016/S0140-6736(11)60174-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014.

Authors:  Nancy J Cox; Julian Hickling; Rebecca Jones; Guus F Rimmelzwaan; Linda C Lambert; John Boslego; Larisa Rudenko; Leena Yeolekar; James S Robertson; Joachim Hombach; Justin R Ortiz
Journal:  Vaccine       Date:  2015-10-23       Impact factor: 3.641

2.  A paradigm shift in vaccine production for pandemic influenza.

Authors:  John Steel
Journal:  Ann Transl Med       Date:  2015-07

Review 3.  Influenza vaccines: an Asia-Pacific perspective.

Authors:  Lance C Jennings
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

4.  Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study.

Authors:  Nayer Khazeni; David W Hutton; Cassandra I F Collins; Alan M Garber; Douglas K Owens
Journal:  Ann Intern Med       Date:  2014-05-20       Impact factor: 25.391

5.  Using a Dynamic Model to Consider Optimal Antiviral Stockpile Size in the Face of Pandemic Influenza Uncertainty.

Authors:  Amy L Greer; Dena Schanzer
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

6.  Protease activation mutants elicit protective immunity against highly pathogenic avian influenza viruses of subtype H7 in chickens and mice.

Authors:  Ralf Wagner; Gülsah Gabriel; Matthias Schlesner; Nina Alex; Astrid Herwig; Ortrud Werner; Hans-Dieter Klenk
Journal:  Emerg Microbes Infect       Date:  2013-02-27       Impact factor: 7.163

7.  A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individuals.

Authors:  Hartmut J Ehrlich; Julia Singer; Gregory Berezuk; Sandor Fritsch; Gerald Aichinger; Mary Kate Hart; Wael El-Amin; Daniel Portsmouth; Otfried Kistner; P Noel Barrett
Journal:  Clin Infect Dis       Date:  2012-01-19       Impact factor: 9.079

8.  Antiviral strategies for emerging influenza viruses in remote communities.

Authors:  Marek Laskowski; Amy L Greer; Seyed M Moghadas
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.